Tech Company Financing Transactions
Natural Cycles Funding Round
Lauxera Capital Partners, JPMorgan Chase Bank and Point72 Ventures participated in a $55 million Series C funding round for Natural Cycles. This venture round was announced on 5/29/2024.
Transaction Overview
Company Name
Announced On
5/29/2024
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$55,000,000
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Sankt Eriksgatan 63B
Stockholm, 112 34
SE
Stockholm, 112 34
SE
Phone
Undisclosed
Website
Email Address
Overview
We have developed the only digital method of birth control cleared by regulators both in the US and in Europe. Effective, natural, and backed by clinical research - Natural Cycles has been cleared by the US FDA and CE marked in Europe. Today we have a growing user base, who are happy to have found a method of birth control that is right for them and that allows them to get to know their bodies and cycles. No matter what your choice is, we believe that every woman should know that understanding how your cycle works matters.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Raoul Scherwitzl
Chief Financial Officer
Simon Afeworki
Co-Founder
Elina Berglund
Browse more venture capital transactions:
Prev: 5/29/2024: Maven AGI venture capital transaction
Next: 5/29/2024: Authentic Insurance venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs